Literature DB >> 26231669

Human breast cancer bone metastasis in vitro and in vivo: a novel 3D model system for studies of tumour cell-bone cell interactions.

I Holen1, F Nutter1, J M Wilkinson2, C A Evans1, P Avgoustou1, Penelope D Ottewell3.   

Abstract

Bone is established as the preferred site of breast cancer metastasis. However, the precise mechanisms responsible for this preference remain unidentified. In order to improve outcome for patients with advanced breast cancer and skeletal involvement, we need to better understand how this process is initiated and regulated. As bone metastasis cannot be easily studied in patients, researchers have to date mainly relied on in vivo xenograft models. A major limitation of these is that they do not contain a human bone microenvironment, increasingly considered to be an important component of metastases. In order to address this shortcoming, we have developed a novel humanised bone model, where 1 × 10(5) luciferase-expressing MDA-MB-231 or T47D human breast tumour cells are seeded on viable human subchaodral bone discs in vitro. These discs contain functional osteoclasts 2-weeks after in vitro culture and positive staining for calcine 1-week after culture demonstrating active bone resorption/formation. In vitro inoculation of MDA-MB-231 or T47D cells colonised human bone cores and remained viable for <4 weeks, however, use of matrigel to enhance adhesion or a moving platform to increase diffusion of nutrients provided no additional advantage. Following colonisation by the tumour cells, bone discs pre-seeded with MDA-MB-231 cells were implanted subcutaneously into NOD SCID mice, and tumour growth monitored using in vivo imaging for up to 6 weeks. Tumour growth progressed in human bone discs in 80 % of the animals mimicking the later stages of human bone metastasis. Immunohistochemical and PCR analysis revealed that growing MDA-MB-231 cells in human bone resulted in these cells acquiring a molecular phenotype previously associated with breast cancer bone metastases. MDA-MB-231 cells grown in human bone discs showed increased expression of IL-1B, HRAS and MMP9 and decreased expression of S100A4, whereas, DKK2 and FN1 were unaltered compared with the same cells grown in mammary fat pads of mice not implanted with human bone discs.

Entities:  

Keywords:  3D models; Bone; Breast cancer; Metastasis

Mesh:

Year:  2015        PMID: 26231669     DOI: 10.1007/s10585-015-9737-y

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  39 in total

1.  Three-dimensional cancer-bone metastasis model using ex-vivo co-cultures of live calvarial bones and cancer cells.

Authors:  Paul Curtin; Helen Youm; Erdjan Salih
Journal:  Biomaterials       Date:  2011-11-08       Impact factor: 12.479

2.  A novel model of dormancy for bone metastatic breast cancer cells.

Authors:  Rebecca Marlow; Gabriella Honeth; Sara Lombardi; Massimiliano Cariati; Sonya Hessey; Aikaterini Pipili; Veronica Mariotti; Bharath Buchupalli; Katie Foster; Dominique Bonnet; Agamemnon Grigoriadis; Pranela Rameshwar; Anand Purushotham; Andrew Tutt; Gabriela Dontu
Journal:  Cancer Res       Date:  2013-10-21       Impact factor: 12.701

Review 3.  Microenvironmental regulation of tumor progression and metastasis.

Authors:  Daniela F Quail; Johanna A Joyce
Journal:  Nat Med       Date:  2013-11       Impact factor: 53.440

4.  Bone metastasis in a novel breast cancer mouse model containing human breast and human bone.

Authors:  Tian-Song Xia; Guo-Zhu Wang; Qiang Ding; Xiao-An Liu; Wen-Bin Zhou; Yi-Fen Zhang; Xiao-Ming Zha; Qing Du; Xiao-Jian Ni; Jue Wang; Su-Yu Miao; Shui Wang
Journal:  Breast Cancer Res Treat       Date:  2011-06-03       Impact factor: 4.872

5.  Co-culture of primary human mammary fibroblasts and MCF-7 cells as an in vitro breast cancer model.

Authors:  Marjoke Heneweer; Martine Muusse; Milou Dingemans; Paul C de Jong; Martin van den Berg; J Thomas Sanderson
Journal:  Toxicol Sci       Date:  2004-11-03       Impact factor: 4.849

6.  OPG-Fc inhibits ovariectomy-induced growth of disseminated breast cancer cells in bone.

Authors:  Penelope D Ottewell; Ning Wang; Hannah K Brown; C Anne Fowles; Peter I Croucher; Colby L Eaton; Ingunn Holen
Journal:  Int J Cancer       Date:  2015-02-02       Impact factor: 7.396

7.  Mechanisms and pathways of bone metastasis: challenges and pitfalls of performing molecular research on patient samples.

Authors:  T R Cawthorn; E Amir; R Broom; O Freedman; D Gianfelice; D Barth; D Wang; I Holen; S J Done; M Clemons
Journal:  Clin Exp Metastasis       Date:  2009-08-21       Impact factor: 5.150

Review 8.  Targeting tumor-stromal interactions in bone metastasis.

Authors:  Mark Esposito; Yibin Kang
Journal:  Pharmacol Ther       Date:  2013-10-15       Impact factor: 12.310

9.  Zoledronic acid has differential antitumor activity in the pre- and postmenopausal bone microenvironment in vivo.

Authors:  Penelope D Ottewell; Ning Wang; Hannah K Brown; Kimberly J Reeves; C Anne Fowles; Peter I Croucher; Colby L Eaton; Ingunn Holen
Journal:  Clin Cancer Res       Date:  2014-03-31       Impact factor: 12.531

10.  Metastatic skull tumors: MRI features and a new conventional classification.

Authors:  Koichi Mitsuya; Yoko Nakasu; Satoshi Horiguchi; Hideyuki Harada; Tetsuo Nishimura; Sachiko Yuen; Koiku Asakura; Masahiro Endo
Journal:  J Neurooncol       Date:  2010-11-26       Impact factor: 4.130

View more
  21 in total

1.  Editorial: special issue introduction.

Authors:  Jonathan P Sleeman
Journal:  Clin Exp Metastasis       Date:  2017-04       Impact factor: 5.150

2.  Murine models of breast cancer bone metastasis.

Authors:  Laura E Wright; Penelope D Ottewell; Nadia Rucci; Olivier Peyruchaud; Gabriel M Pagnotti; Antonella Chiechi; Jeroen T Buijs; Julie A Sterling
Journal:  Bonekey Rep       Date:  2016-05-11

Review 3.  Targeting the Wnt signaling pathway for breast cancer bone metastasis therapy.

Authors:  Jingyao Cui; Haoran Chen; Kaiwen Zhang; Xin Li
Journal:  J Mol Med (Berl)       Date:  2021-11-25       Impact factor: 4.599

4.  Mechanobiological evaluation of prostate cancer metastasis to bone using an in vitro prostate cancer testbed.

Authors:  Md Shahjahan Molla; Dinesh R Katti; Kalpana S Katti
Journal:  J Biomech       Date:  2020-11-21       Impact factor: 2.712

Review 5.  Advances in the development of improved animal-free models for use in breast cancer biomedical research.

Authors:  Sophie Roberts; Valerie Speirs
Journal:  Biophys Rev       Date:  2017-07-26

6.  An in vitro 3D bone metastasis model by using a human bone tissue culture and human sex-related cancer cells.

Authors:  Francesca Salamanna; Veronica Borsari; Silvia Brogini; Gianluca Giavaresi; Annapaola Parrilli; Simona Cepollaro; Matteo Cadossi; Lucia Martini; Antonio Mazzotti; Milena Fini
Journal:  Oncotarget       Date:  2016-11-22

Review 7.  The Role of Inflammation in Breast and Prostate Cancer Metastasis to Bone.

Authors:  Andy Göbel; Stefania Dell'Endice; Nikolai Jaschke; Sophie Pählig; Amna Shahid; Lorenz C Hofbauer; Tilman D Rachner
Journal:  Int J Mol Sci       Date:  2021-05-11       Impact factor: 5.923

8.  Fluorescent Silica Nanoparticles to Label Metastatic Tumor Cells in Mineralized Bone Microenvironments.

Authors:  Aaron E Chiou; Joshua A Hinckley; Rupal Khaitan; Neta Varsano; Jonathan Wang; Henry F Malarkey; Christopher J Hernandez; Rebecca M Williams; Lara A Estroff; Steve Weiner; Lia Addadi; Ulrich B Wiesner; Claudia Fischbach
Journal:  Small       Date:  2020-05-28       Impact factor: 13.281

9.  New 3D-Culture Approaches to Study Interactions of Bone Marrow Adipocytes with Metastatic Prostate Cancer Cells.

Authors:  Mackenzie Katheryn Herroon; Jonathan Driscoll Diedrich; Izabela Podgorski
Journal:  Front Endocrinol (Lausanne)       Date:  2016-07-06       Impact factor: 5.555

Review 10.  A systematic review on in vitro 3D bone metastases models: A new horizon to recapitulate the native clinical scenario?

Authors:  Francesca Salamanna; Deyanira Contartese; Melania Maglio; Milena Fini
Journal:  Oncotarget       Date:  2016-07-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.